Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway-Reference-Cited by-同舟云学术

Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway

Published:2019-05-24 Issue:1 Volume:18 Page:
ISSN:1476-511X
Container-title:Lipids in Health and Disease
language:en
Short-container-title:Lipids Health Dis

Author:

Chang Ligong,Fang Surong,Chen Yubao,Yang Zhenhua,Yuan Yuan,Zhang Jing,Ye Liang,Gu Wei

Funder

Jiangsu Provincial Special Program of Medicine Science

Jiangsu Natural Science Foundation

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12944-019-1058-8.pdf

Reference42 articles.

1. Gridelli C, Rossi A, Carbone DP, et al. Non-small-cell lung cancer. Nat Rev Dis Primers. 2015;1:15009.

2. Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21(3):297–308.

3. Vander Heiden MG, Lunt SY, Dayton TL, et al. Metabolic pathway alterations that support cell proliferation. Cold Spring Harb Symp Quant Biol. 2012;76:325–34.

4. Beloribidjefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis. 2016;5(1):e189.

5. Lupu R, Menendez JA. Targeting fatty acid synthase in breast and endometrial cancer: an alternative to selective estrogen receptor modulators? Endocrinology. 2006;147(9):4056–66.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells;Heliyon;2024-09

2. Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways;Diseases;2024-05-06

3. Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors;Cancers;2024-03-28

4. Lipid droplets provide metabolic flexibility for cancer progression;FEBS Letters;2024-02-07

5. Regulation of fatty acid synthase on tumor and progress in the development of related therapies;Chinese Medical Journal;2024-01-26